We are live on
!
Find out more
HP
Hound Partners Portfolio holdings
AUM
$799M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+4.77%
1 Year Est. Return
+9.54%
3 Year Est. Return
+2.99%
5 Year Est. Return
-6.92%
10 Year Est. Return
+145.19%
AUM
$4.59B
AUM Growth
+$69.3M
(+1.5%)
Cap. Flow
-$55.3M
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
80.43%
Holding
30
New
2
Increased
14
Reduced
6
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$607M |
| 2 |
IPXL
Impax Laboratories, Inc.
IPXL
|
+$232M |
| 3 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$144M |
| 4 |
LKQ Corp
LKQ
|
+$114M |
| 5 |
ANDV
Andeavor
ANDV
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$231M |
| 2 |
Sensata Technologies
ST
|
+$183M |
| 3 |
Carter's
CRI
|
+$98.8M |
| 4 |
TriNet
TNET
|
+$75.6M |
| 5 |
INFA
INFORMATICA CORP
INFA
|
+$59.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.87% |
| 2 | Consumer Discretionary | 16.17% |
| 3 | Industrials | 13.51% |
| 4 | Financials | 7.56% |
| 5 | Technology | 7.05% |
Similar funds
KWMG
GWA
CG
LWM
NW
IAM
AAM
1IA
Hound Partners's Q2 2015 Portfolio in Review
As of Q2 2015, Hound Partners held 30 positions worth $4.59B, up 1.5% from $4.52B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Hound Partners's Q2 2015 filing shows 2 new, 14 increased, 6 reduced and 7 closed positions. Its largest new stake was Bausch Health: 2,736,647 shares worth $608M. The largest sale was SALIX PHARMACEUTICALS LTD DEL, an estimated $231M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 5.9% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Hound Partners's largest Q2 2015 buy was Bausch Health: 2,736,647 shares worth $608M.
- Hound Partners added most to Impax Laboratories, Inc. in Q2 2015, an estimated $232M increase.
- Hound Partners's biggest Q2 2015 reduction was Carter's, cutting an estimated $98.8M.
- Hound Partners fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $231M.
- Hound Partners's ten largest holdings make up 80% of its $4.59B portfolio in Q2 2015.
- Hound Partners opened 2 new positions and closed 7 in Q2 2015.
- Hound Partners's portfolio value rose 1.5% quarter-over-quarter to $4.59B.
Based on Hound Partners's 13F filing for Q2 2015, filed 14 Aug 2015.